Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

The best concentration of triamcinolone acetonide for treating alopecia areata is still unclear.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

Topical cetirizine may help increase hair count in androgenetic alopecia.

Microneedling with triamcinolone is a safe, effective, and less painful treatment for alopecia areata.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Hair restoration can cause severe seizures due to combined drug toxicity.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.